Eli Lilly Buys Bowel Disease Drug Developer Morphic In $3.2 Billion Deal
Nasdaq Index, Dow Jones, S&P 500 News: Morphic Holding Shares Surge Over 75%; Alibaba Group Stumbles
Eli Lilly's First Biotech Deal Of 2024, Buys Chronic Disease Player Morphic For $3.2B
Eli Lilly to Buy Morphic for $3.2 Billion. Morphic Stock Surges 78%.
Morphic's stock rockets after $3.2 billion buyout deal with Eli Lilly
Eli Lilly to acquire Morphic Holding for $3.2 billion